Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Anlotinib plus Pemetrexed
DRUG
2 trials
Sponsors
Guangdong Association of Clinical Trials
, Henan Provincial People's Hospital
Conditions
Advanced Non-squamous NSCLC
Non-squamous Cell Non-Small Cell Lung Cancer
Phase 2
Study of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLC
NCT03778138
Henan Provincial People's Hospital
Non-squamous Cell Non-Small Cell Lung Cancer
Start: 2019-01-01
End: 2020-12-31
Target: 51
Updated: 2018-12-19
Phase 4
Anlotinib Plus Pemetrexed or Pemetrexed for Previously Untreated Elderly (>=70) or PS=2 Non-squamous NSCLC
NCT03768037
Guangdong Association of Clinical Trials
Advanced Non-squamous NSCLC
Start: 2018-11-26
End: 2020-11-26
Target: 106
Updated: 2018-12-07